Single sevoflurane exposure increases methyl‑CpG island binding protein 2 phosphorylation in the hippocampus of developing mice

Han,Xiao‑Dan; Li,Min; Zhang,Xiao‑Guang; Xue,Zhang‑Gang; Cang,Jing

doi:10.3892/mmr.2014.2751

Single sevoflurane exposure increases methyl‑CpG island binding protein 2 phosphorylation in the hippocampus of developing mice

Authors:
- Xiao‑Dan Han
- Min Li
- Xiao‑Guang Zhang
- Zhang‑Gang Xue
- Jing Cang
View Affiliations

Affiliations: Department of Anesthesia, Zhongshan Hospital, Fudan University, Shanghai 200032, P.R. China
Published online on: October 23, 2014 https://doi.org/10.3892/mmr.2014.2751
Pages: 226-230

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Sevoflurane is an inhaled anesthetic that is widely used in clinical practice, particularly for pediatric anesthesia. Previous studies have suggested that sevoflurane may induce neurotoxicity in the brains of neonatal mice. In the present study, the possible mechanism of neurodegeneration induced by sevoflurane in the developing brain, and the possibility that memantine treatment is able to reverse this phenomenon, were investigated. On postnatal day 7 (P7) C57BL/6 mice were continuously exposed to 1.5% sevoflurane for 2 h following pre‑injection of saline or memantine. Methyl‑CpG island binding protein 2 (MeCP2), cAMP response element‑binding protein (CREB) and brain‑derived neurotrophic factor (BDNF) expression in the hippocampus was measured by western blotting. Exposure to 1.5% sevoflurane resulted in increased MeCP2 phosphorylation in the hippocampus, which was reversed by memantine injection. However, neither CREB phosphorylation nor BDNF expression were significantly altered by sevoflurane treatment. The current study indicated that sevoflurane causes neurotoxicity in the developing brain, and that this may be attributed to increased MeCP2 phosphorylation in the hippocampus. It was also demonstrated that this neurotoxicity can be prevented by the N‑methyl‑D‑aspartate glutamate receptor inhibitor memantine.

View Figures

View References

1	Jevtovic-Todorovic V, Hartman RE, Izumi Y, et al: Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J Neurosci. 23:876–882. 2003.
2	Liang G, Ward C, Peng J, Zhao Y, Huang B and Wei H: Isoflurane causes greater neurodegeneration than an equivalent exposure of sevoflurane in the developing brain of neonatal mice. Anesthesiology. 112:1325–1334. 2010. View Article : Google Scholar : PubMed/NCBI
3	Loepke AW, Istaphanous GK, McAuliffe JR, et al: The effects of neonatal isoflurane exposure in mice on brain cell viability, adult behavior, learning, and memory. Anesth Analg. 108:90–104. 2009. View Article : Google Scholar : PubMed/NCBI
4	Head BP, Patel HH, Niesman IR, Drummond JC, Roth DM and Patel PM: Inhibition of p75 neurotrophin receptor attenuates isoflurane-mediated neuronal apoptosis in the neonatal central nervous system. Anesthesiology. 110:813–825. 2009. View Article : Google Scholar
5	Satomoto M, Satoh Y, Terui K, et al: Neonatal exposure to sevoflurane induces abnormal social behaviors and deficits in fear conditioning in mice. Anesthesiology. 110:628–637. 2009. View Article : Google Scholar
6	Kishi N and Macklis JD: MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions. Mol Cell Neurosci. 27:306–321. 2004. View Article : Google Scholar : PubMed/NCBI
7	Nguyen MV, Du F, Felice CA, et al: MeCP2 is critical for maintaining mature neuronal networks and global brain anatomy during late stages of postnatal brain development and in the mature adult brain. J Neurosci. 32:10021–10034. 2012. View Article : Google Scholar : PubMed/NCBI
8	Kron M, Howell CJ, Adams IT, et al: Brain activity mapping in Mecp2 mutant mice reveals functional deficits in forebrain circuits, including key nodes in the default mode network, that are reversed with ketamine treatment. J Neurosci. 32:13860–13872. 2012. View Article : Google Scholar
9	Cohen S, Gabel HW, Hemberg M, et al: Genome-wide activity-dependent MeCP2 phosphorylation regulates nervous system development and function. Neuron. 72:72–85. 2011. View Article : Google Scholar : PubMed/NCBI
10	Fuks F, Hurd PJ, Wolf D, Nan X, Bird AP and Kouzarides T: The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J Biol Chem. 278:4035–4040. 2003. View Article : Google Scholar : PubMed/NCBI
11	Bienvenu T and Chelly J: Molecular genetics of Rett syndrome: when DNA methylation goes unrecognized. Nat Rev Genet. 7:415–426. 2006. View Article : Google Scholar : PubMed/NCBI
12	Zhou Z, Hong EJ, Cohen S, et al: Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation. Neuron. 52:255–269. 2006. View Article : Google Scholar : PubMed/NCBI
13	Li H, Zhong X, Chau KF, Williams EC and Chang Q: Loss of activity-induced phosphorylation of MeCP2 enhances synaptogenesis, LTP and spatial memory. Nat Neurosci. 14:1001–1008. 2011. View Article : Google Scholar : PubMed/NCBI
14	Tao X, Finkbeiner S, Arnold DB, Shaywitz AJ and Greenberg ME: Ca²⁺ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron. 20:709–726. 1998.
15	Areosa Sastre ASF and McShane R: Memantine for dementia. The Cochrane Library. 2006
16	Mount C and Downton C: Alzheimer disease: progress or profit? Nat Med. 12:780–784. 2006. View Article : Google Scholar : PubMed/NCBI
17	Zhang X, Xue Z and Sun A: Subclinical concentration of sevoflurane potentiates neuronal apoptosis in the developing C57BL/6 mouse brain. Neurosci Lett. 447:109–114. 2008. View Article : Google Scholar : PubMed/NCBI
18	Simon DK, Prusky GT, O’Leary DD and Constantine-Paton M: N-methyl-D-aspartate receptor antagonists disrupt the formation of a mammalian neural map. Proc Natl Acad Sci USA. 89:10593–10597. 1992. View Article : Google Scholar : PubMed/NCBI
19	Hardingham GE, Fukunaga Y and Bading H: Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat Neurosci. 5:405–414. 2002.PubMed/NCBI
20	Johnson SA, Young C and Olney JW: Isoflurane-induced neuroapoptosis in the developing brain of nonhypoglycemic mice. J Neurosurg Anesthesiol. 20:21–28. 2008. View Article : Google Scholar : PubMed/NCBI
21	Yon JH, Daniel-Johnson J, Carter LB and Jevtovic-Todorovic V: Anesthesia induces neuronal cell death in the developing rat brain via the intrinsic and extrinsic apoptotic pathways. Neuroscience. 135:815–827. 2005. View Article : Google Scholar : PubMed/NCBI
22	Durand S, Patrizi A, Quast KB, et al: NMDA receptor regulation prevents regression of visual cortical function in the absence of Mecp2. Neuron. 76:1078–1090. 2012. View Article : Google Scholar : PubMed/NCBI
23	Lee S, Kim W, Ham BJ, Chen W, Bear MF and Yoon BJ: Activity-dependent NR2B expression is mediated by MeCP2-dependent epigenetic regulation. Biochem Biophys Res Commun. 377:930–934. 2008. View Article : Google Scholar : PubMed/NCBI
24	Carouge D, Host L, Aunis D, Zwiller J and Anglard P: CDKL5 is a brain MeCP2 target gene regulated by DNA methylation. Neurobiol Dis. 38:414–424. 2010. View Article : Google Scholar : PubMed/NCBI
25	Im HI, Hollander JA, Bali P and Kenny PJ: MeCP2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212. Nat Neurosci. 13:1120–1127. 2010. View Article : Google Scholar : PubMed/NCBI
26	Xia P, Chen HS, Zhang D and Lipton SA: Memantine preferentially blocks extrasynaptic over synaptic NMDA receptor currents in hippocampal autapses. J Neurosci. 30:11246–11250. 2010. View Article : Google Scholar : PubMed/NCBI